Can early diagnosis and effective management combat the irresistible rise of COPD?

British Journal of General Practice

Volumn 56, Issue 530, 2006, Pages 652-654

  Jones, Rupert ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; LONG ACTING DRUG; MUCOLYTIC AGENT; OXYGEN; STEROID;

ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMA; DIET THERAPY; DISEASE EXACERBATION; DISEASE SEVERITY; EDITORIAL; FORCED EXPIRATORY VOLUME; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; HYPERCAPNIA; HYPOXIA; INCIDENCE; META ANALYSIS; NATIONAL HEALTH SERVICE; OXYGEN THERAPY; PHYSICAL ACTIVITY; PREVALENCE; PROGNOSIS; PULMONARY REHABILITATION; QUALITY OF LIFE; RESPIRATORY FAILURE; SMOKING CESSATION; SPIROMETRY; SYSTEMATIC REVIEW;

EARLY DIAGNOSIS; FAMILY PRACTICE; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING CESSATION;

EID: 33748677930     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (25)

1. Department of Health. Our health, our lives our say. London: Department of Health 2006.
2. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977; 1: 1645-1648.
3. Geijer RMM, Sachs APE, Verheij TJM, et al. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5 year follow-up study. Br J Gen Pract 2006; 56: 656-661.
4. Vestbo J, Hogg JC. Convergence of the epidemiology and pathology of COPD. Thorax 2006; 61: 86-88.
5. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994; 272: 1497-1505.
6. Celli B. Chronic obstructive pulmonary disease. From unjustified nihilism to evidence-based optimism. Proc Am Thorac Soc 2006; 3: 58-65.
7. Pitta F, Troosters T, Spruit MA, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 972-977.
8. Bernard S, Whittom F, Leblanc P, et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 896-901.
9. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1791-1797.
10. Pitta F, Troosters T, Probst VS, et al. Physical activity and hospitalization for exacerbation of COPD. Chest 2006; 129: 536-544.
11. Hyland ME, Jones RCM, Hanney KE, The Lung Information Needs Questionnaire: development, preliminary validation and findings. Respir Med 2006; 100: in press.
12. National Collaborating Centre for Chronic Conditions. Chronic Obstructive Pulmonary Disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004; 59(Suppl 1): i1-i232.
13. Department of Health, Chief Medical Officer. It takes your breath away. The impact of chronic obstructive pulmonary disease. Annual Report. London: Department of Health, 2004.
14. Burge PS, Calverley PM, Jones PW, et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000, 320: 1297-1303.
15. Sin DD, Wu L, Anderson JA, et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 2005; 60: 992-997.
16. Vestbo J. The TORCH (towards a revolution in COPD, health) survival study protocol. Eur Respir J 2004; 24: 206-210.
17. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847-852.
18. Rodríguez-Roisin R. COPD exacerbations 5: management. Thorax 2006; 61: 535-544.
19. Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Resp J 2006; 27(4): in press.
20. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000; 160: 1683-1689.
21. Van Schayck CP, Loozen JM, Wagena E, et al. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ 2002; 324: 1370.
22. Healthcare Commission. Clearing the air - a national study on chronic obstructive pulmonary disease. London: Healthcare Commission, 2006.
23. British Lung Foundation. Lost in translation - bridging the communication gap in COPD. London: British Lung Foundation, 2006.
24. British Thoracic Society. The burden of lung disease (2nd edn). London: British Thoracic Society, 2006.
25. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD Bethesda, MD: Global Initiative for Chronic Obstructive Lung Disease, 2005.